Report - Management der rezidivierten ... - cme.medlearning.de · TOWER: Blinatumomab in Relapsed / Refractory ALL Results of Remission Induction (CR/CRp/CRi) by Subgroups and Outcome by Salvage

Please pass captcha verification before submit form